Martins Eduardo Bruno 4
4 · Sagimet Biosciences Inc. · Filed Nov 21, 2023
Insider Transaction Report
Form 4
Martins Eduardo Bruno
Chief Medical Officer
Transactions
- Award
Series A Common Stock
2023-11-17+89,570→ 89,570 total
Footnotes (1)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Series A Common Stock upon vesting and settlement. 25% of the RSUs shall vest on July 18, 2024, with the remainder vesting in three equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date.